Pharmacokinetics and pharmacodynamics of six epoetin alfa dosing regimens in anemic critically ill patients without acute blood loss. (opent nieuw venster)

Arroliga AC, Guntupalli KK, Beaver JS, Langholff W, Marino K, Kelly K

Bron‎: Crit Care Med 2009;37(4):1299-307.

Geïndexeerd‎: PubMed 19242343

DOI‎: 10.1097/CCM.0b013e31819cec94

https://www.ncbi.nlm.nih.gov/pubmed/19242343 (opent nieuw venster)

Recombinant human erythropoietin therapy in critically ill Jehovah's Witnesses. (opent nieuw venster)

Ball AM, Winstead PS.

Bron‎: Pharmacotherapy 2008;28(11):1383-90.

Geïndexeerd‎: PubMed 18956998

DOI‎: 10.1592/phco.28.11.1383

https://www.ncbi.nlm.nih.gov/pubmed/18956998 (opent nieuw venster)

Reducing postburn injury anemia in a Jehovah's Witness patient. (opent nieuw venster)

Barsun A, Sen S, Palmieri TL, Greenhalgh DG

Bron‎: J Burn Care Res 2014;35(4):e258-61.

Geïndexeerd‎: PubMed 24121804

DOI‎: 10.1097/BCR.0b013e3182a366c5

https://www.ncbi.nlm.nih.gov/pubmed/24121804 (opent nieuw venster)

A US multicenter, retrospective, observational study of erythropoiesis-stimulating agent utilization in anemic, critically ill patients admitted to the intensive care unit. (opent nieuw venster)

Brophy GM, Sheehan V, Shapiro MJ, Lottenberg L, Scarlata D, Audhya P; ASSESS Study Group and Amgen Inc

Bron‎: Clin Ther 2008;30(12):2324-34.

Geïndexeerd‎: PubMed 19167591

DOI‎: 10.1016/j.clinthera.2008.12.024

https://www.ncbi.nlm.nih.gov/pubmed/19167591 (opent nieuw venster)

Severe acute anemia after liver transplantation in an elderly Jehovah's Witness treated with high-dose erythropoietin and ferric carboxymaltose: a case report. (opent nieuw venster)

Brunetta DM, Kaufman J, De Santis GC, Mesquita DF, Souza FN, Garcia JH.

Bron‎: Transplant Proc 2015;47(8):2548-51.

Geïndexeerd‎: PubMed 26518969

DOI‎: 10.1016/j.transproceed.2015.09.014

https://www.ncbi.nlm.nih.gov/pubmed/26518969 (opent nieuw venster)

Recombinant human erythropoietin in severe anaemia: issues of dosing and duration. (opent nieuw venster)

Charles A, Purtill M, Napolitano LM.

Bron‎: Anaesth Intensive Care 2006;34(6):793-6.

Geïndexeerd‎: PubMed 17183900

https://www.ncbi.nlm.nih.gov/pubmed/17183900 (opent nieuw venster)

Efficacy of recombinant human erythropoietin in the critically ill patient: a randomized, double-blind, placebo-controlled trial. (opent nieuw venster)

Corwin HL, Gettinger A, Rodriguez RM, Pearl RG, Gubler KD, Enny C, Colton T, Corwin MJ.

Bron‎: Crit Care Med 1999;27(11):2346-50.

Geïndexeerd‎: PubMed 10579246

https://www.ncbi.nlm.nih.gov/pubmed/10579246 (opent nieuw venster)

Erythropoietin for critically ill trauma patients: a missed opportunity? (opent nieuw venster)

Corwin HL, Napolitano LM

Bron‎: J Trauma Acute Care Surg 2014;77(5):774-9.

Geïndexeerd‎: PubMed 25494432

DOI‎: 10.1097/TA.0000000000000442

https://www.ncbi.nlm.nih.gov/pubmed/25494432 (opent nieuw venster)

Postoperative management of severe acute anemia in a Jehovah's Witness. (opent nieuw venster)

de Araújo Azi LM, Lopes FM, Garcia LV

Bron‎: Transfusion 2014;54(4):1153-7.

Geïndexeerd‎: PubMed 24117834

DOI‎: 10.1111/trf.12424

https://www.ncbi.nlm.nih.gov/pubmed/24117834 (opent nieuw venster)

Restrictive transfusion in geriatric trauma patients. (opent nieuw venster)

DeLeon AN, Uecker JM, Stafford SV, Ali S, Clark A, Brown CV

Bron‎: Am Surg 2016;82(1):85-8.

Geïndexeerd‎: PubMed 26802863

https://www.ncbi.nlm.nih.gov/pubmed/26802863 (opent nieuw venster)

High-dose recombinant human erythropoietin stimulates reticulocyte production in patients with multiple organ dysfunction syndrome. (opent nieuw venster)

Gabriel A, Kozek S, Chiari A, Fitzgerald R, Grabner C, Geissler K, Zimpfer M, Stockenhuber F, Bircher NG

Bron‎: J Trauma 1998;44(2):361-7.

Geïndexeerd‎: PubMed 9498512

DOI‎: 10.1097/00005373-199802000-00023

https://www.ncbi.nlm.nih.gov/pubmed/9498512 (opent nieuw venster)

Recombinant human erythropoietin therapy in critically ill patients: a dose-response study [ISRCTN48523317]. (opent nieuw venster)

Georgopoulos D, Matamis D, Routsi C, Michalopoulos A, Maggina N, Dimopoulos G, Zakynthinos E, Nakos G, Thomopoulos G, Mandragos K, Maniatis A; Critical Care Clinical Trials Greek Group.

Bron‎: Crit Care 2005;9(5):R508-15.

Geïndexeerd‎: PubMed 16277712

DOI‎: 10.1186/cc3786

https://www.ncbi.nlm.nih.gov/pubmed/16277712 (opent nieuw venster)

Management of a Jehovah's Witness patient with sepsis and profuse bleeding after emergency coronary artery bypass graft surgery: rethinking the critical threshold of oxygen delivery. (opent nieuw venster)

Hong T, Shander A, Agarwal S, Castresana M.

Bron‎: A A Case Rep 2015;4(10):127-31.

Geïndexeerd‎: PubMed 25974416

DOI‎: 10.1213/XAA.0000000000000144

https://www.ncbi.nlm.nih.gov/pubmed/25974416 (opent nieuw venster)

Management strategies for perioperative anaemia in the severely burn-injured Jehovah's Witness patients who decline a blood transfusion: a systematic review with illustrative case reports. (opent nieuw venster)

Jung M, Harish V, Wijewardena A, Kerridge I, Gillies R

Bron‎: Burns. 2023 49(3):716-29. Epub 2022 Jul 18.

Geïndexeerd‎: PubMed 35941026

DOI‎: 10.1016/j.burns.2022.07.002

https://pubmed.ncbi.nlm.nih.gov/35941026/ (opent nieuw venster)

Long-term ECMO treatment in Jehovah's Witness patient without transfusions. (opent nieuw venster)

Lindholm J, Palmér K, Frenckner B.

Bron‎: Perfusion 2012;27(4):332-4.

Geïndexeerd‎: PubMed 22496111

DOI‎: 10.1177/0267659112444328

https://www.ncbi.nlm.nih.gov/pubmed/22496111 (opent nieuw venster)

Outcomes with the use of recombinant human erythropoietin in critically ill burn patients. (opent nieuw venster)

Lundy JB, Hetz K, Chung KK, Renz EM, White CE, King BT, Huzar T, Wolf SE, Blackbourne LH

Bron‎: Am Surg 2010;76(9):951-6.

Geïndexeerd‎: PubMed 20836341

https://www.ncbi.nlm.nih.gov/pubmed/20836341 (opent nieuw venster)

Safety of off-label erythropoiesis stimulating agents in critically ill patients: a meta-analysis. (opent nieuw venster)

Mesgarpour B, Heidinger BH, Schwameis M, Kienbacher C, Walsh C, Schmitz S, Herkner H.

Bron‎: Intensive Care Med 2013;39(11):1896-908.

Geïndexeerd‎: PubMed 23928897

DOI‎: 10.1007/s00134-013-3030-9

https://www.ncbi.nlm.nih.gov/pubmed/23928897 (opent nieuw venster)

Transfusion-free treatment strategies for acute anemia in critical care. (opent nieuw venster)

Morgan CA, Byul Sarah S, Forest CP.

Bron‎: JAAPA 2016;29(8):38-44.

Geïndexeerd‎: PubMed 27467297

DOI‎: 10.1097/01.JAA.0000488695.96294.33

https://www.ncbi.nlm.nih.gov/pubmed/27467297 (opent nieuw venster)

Improved survival of critically ill trauma patients treated with recombinant human erythropoietin. (opent nieuw venster)

Napolitano LM, Fabian TC, Kelly KM, Bailey JA, Block EF, Langholff W, Enny C, Corwin HL.

Bron‎: J Trauma 2008;65(2):285-97.

Geïndexeerd‎: PubMed 18695463

DOI‎: 10.1097/TA.0b013e31817f2c6e

https://www.ncbi.nlm.nih.gov/pubmed/18695463 (opent nieuw venster)

Reticulocyte counts and their relation to hemoglobin levels in trauma patients. (opent nieuw venster)

Otterman ML, Nijboer JM, van der Horst IC, van Meurs M, ten Duis HJ, Nijsten MW

Bron‎: J Trauma 2009;67(1):121-4.

Geïndexeerd‎: PubMed 19590320

DOI‎: 10.1097/TA.0b013e318187a848

https://www.ncbi.nlm.nih.gov/pubmed/19590320 (opent nieuw venster)

Randomized, double-blind, placebo-controlled trial of effects of enteral iron supplementation on anemia and risk of infection during surgical critical illness. (opent nieuw venster)

Pieracci FM, Henderson P, Rodney JR, Holena DN, Genisca A, Ip I, Benkert S, Hydo LJ, Eachempati SR, Shou J, Barie PS.

Bron‎: Surg Infect (Larchmt) 2009;10(1):9-19.

Geïndexeerd‎: PubMed 19245362

DOI‎: 10.1089/sur.2008.043

https://www.ncbi.nlm.nih.gov/pubmed/19245362 (opent nieuw venster)

How do we treat life-threatening anemia in a Jehovah's Witness patient? (opent nieuw venster)

Posluszny JA Jr, Napolitano LM.

Bron‎: Transfusion 2014;54(12):3026-34.

Geïndexeerd‎: PubMed 25330835

DOI‎: 10.1111/trf.12888

https://www.ncbi.nlm.nih.gov/pubmed/25330835 (opent nieuw venster)

Recombinant human erythropoietin use in a critically ill Jehovah's Witness after cardiac surgery. (opent nieuw venster)

Price S, Pepper JR, Jaggar SI.

Bron‎: Anesth Analg 2005;101(2):325-7.

Geïndexeerd‎: PubMed 16037136

DOI‎: 10.1213/01.ANE.0000159158.70532.D0

https://www.ncbi.nlm.nih.gov/pubmed/16037136 (opent nieuw venster)

Successful rescue therapy for severe acute anemia: managing the critically ill Jehovah's Witness. (opent nieuw venster)

Rebel A, Beck A, Efron P, Bavry AA, Ang D.

Bron‎: Am Surg 2015;81(6):e263-5.

Geïndexeerd‎: PubMed 26031262

https://www.ncbi.nlm.nih.gov/pubmed/26031262 (opent nieuw venster)

Erythropoietin response is blunted in critically ill patients. (opent nieuw venster)

Rogiers P, Zhang H, Leeman M, Nagler J, Neels H, Mélot C, Vincent JL

Bron‎: Intensive Care Med 1997;23(2):159-62.

Geïndexeerd‎: PubMed 9069000

DOI‎: 10.1007/s001340050310

https://www.ncbi.nlm.nih.gov/pubmed/9069000 (opent nieuw venster)

Life-threatening postoperative blood loss in a Jehovah's Witness, treated with high-dose erythropoietin. (opent nieuw venster)

Schälte G, Janz H, Busse J, Jovanovic V, Rossaint R, Kuhlen R.

Bron‎: Br J Anaesth 2005;94(4):442-4.

Geïndexeerd‎: PubMed 15653706

DOI‎: 10.1093/bja/aei068

https://www.ncbi.nlm.nih.gov/pubmed/15653706 (opent nieuw venster)

Management of anemia in patients who decline blood transfusion. (opent nieuw venster)

Shander A, Goodnough LT

Bron‎: Am J Hematol 2018;93(9):1183-91.

Geïndexeerd‎: PubMed 30033541

DOI‎: 10.1002/ajh.25167

https://pubmed.ncbi.nlm.nih.gov/30033541/ (opent nieuw venster)

Erythropoiesis-stimulating agent administration and survival after severe traumatic brain injury: a prospective study. (opent nieuw venster)

Talving P, Lustenberger T, Inaba K, Lam L, Mohseni S, Chan L, Demetriades D.

Bron‎: Arch Surg 2012;147(3):251-5.

Geïndexeerd‎: PubMed 22430906

DOI‎: 10.1001/archsurg.2011.1838

https://www.ncbi.nlm.nih.gov/pubmed/22430906 (opent nieuw venster)

Intravenous iron following cardiac surgery does not increase the infection rate. (opent nieuw venster)

Torres S, Kuo YH, Morris K, Neibart R, Holtz JB, Davis JM.

Bron‎: Surg Infect (Larchmt) 2006;7(4):361-6.

Geïndexeerd‎: PubMed 16978079

DOI‎: 10.1089/sur.2006.7.361

https://www.ncbi.nlm.nih.gov/pubmed/16978079 (opent nieuw venster)

Erythropoietin improves long-term neurological outcome in acute ischemic stroke patients: a randomized, prospective, placebo-controlled clinical trial. (opent nieuw venster)

Tsai TH, Lu CH, Wallace CG, Chang WN, Chen SF, Huang CR, Tsai NW, Lan MY, Sung PH, Liu CF, Yip HK

Bron‎: Crit Care 2015;19:49.

Geïndexeerd‎: PubMed 25888250

DOI‎: 10.1186/s13054-015-0761-8

https://www.ncbi.nlm.nih.gov/pubmed/25888250 (opent nieuw venster)

Pharmacotherapy for reducing RBC transfusion for patients in the ICU: a systematic review and network meta-analysis. (opent nieuw venster)

Yoshihiro S, Hongo T, Yamamoto M, Taito S, Kataoka Y

Bron‎: Crit Care Med 2024;52(4):618-25.

Geïndexeerd‎: PubMed 37962159

DOI‎: 10.1097/CCM.0000000000006114

https://pubmed.ncbi.nlm.nih.gov/37962159/ (opent nieuw venster)